INKT news · INKT stock

MiNK Therapeutics (INKT) Q2 2026 Earnings Call Transcript

Yahoo Finance · Aug 14, 2026 · Mink Therapeutics Inc (INKT)

Net loss narrowed to $3.1 million as Phase 2 trial for agenT-797 advances in Ukraine.

Original at Yahoo Finance

Not investment advice. Headline and summary only, not a full reprint.